- Meta‘s personal AI agent Muse reached 500,000 users within a week of launch.
- The fast start comes alongside claims that Muse copied rival agent OpenClaw.
- Muse launched on September 8 with privacy as its central pitch.
- The copying dispute echoes long-running accusations about Meta‘s product playbook.
What Happened
Meta‘s AI agent Muse drew 500,000 users in its first week, The Decoder‘s Maximilian Schreiner reported on September 23, 2026 — alongside claims that the product copied OpenClaw, one of the rival agents Meta itself named as competition at launch two weeks ago.
Why It Matters
Half a million users in a week is an early validation that mainstream consumers will try an agent that takes real actions — booking, buying, selling — not just a chatbot. At the same time, the copying allegations revive the most persistent criticism of Meta’s product strategy, from Stories onward: fast-follow the category leader, then win on distribution. For the young personal-agent market, the fight is now about both trust and originality.
Technical Details
Muse runs tasks in what Meta describes as a secure cloud and is operated through messaging. The copying claims concern how closely Muse’s design and capabilities track OpenClaw’s; no court filing was reported at publication, making this a reputational dispute rather than a legal one so far. Adoption numbers are Meta’s own and independent verification of active use — versus sign-ups — is not yet available.
Who’s Affected
OpenClaw faces the classic startup dilemma of a giant shipping its feature set to billions of existing users. Meta gets early momentum for its agent push despite the criticism. Users choosing an agent now weigh Meta’s distribution and polish against the originator’s head start.
What’s Next
Whether OpenClaw escalates the copying claims — publicly or legally — is the immediate question. The more durable metric is retention: if Muse’s 500,000 first-week users keep delegating real tasks to it, Meta’s distribution advantage will matter more than the originality debate.
